Addiction

Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent PortfolioAwakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

Awakn Life Sciences Provides Update on Aminoindane New Chemical Entity Patent Portfolio

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

10 months ago
Nexalin Technology Selected to Join Industry Coalition:  Breaking Barriers to Substance Use RecoveryNexalin Technology Selected to Join Industry Coalition:  Breaking Barriers to Substance Use Recovery

Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery

‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting…

10 months ago
Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLCAwakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC

Awakn Life Sciences Announces Collaboration Agreement with Graft Polymer (UK) PLC

Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

10 months ago
New Hope for the Battle on Drugs: Avenues Recovery Opens State-of-the-Art Drug Rehab in IndianapolisNew Hope for the Battle on Drugs: Avenues Recovery Opens State-of-the-Art Drug Rehab in Indianapolis

New Hope for the Battle on Drugs: Avenues Recovery Opens State-of-the-Art Drug Rehab in Indianapolis

Avenues Recovery Center announced today the grand opening and ribbon-cutting ceremony of their newest facility, Avenues Recovery Center at Indianapolis.INDIANAPOLIS,…

10 months ago
Odyssey Behavioral Healthcare’s 2023 Clinical Outcomes Report Identifies Notable Symptom Improvement From TreatmentOdyssey Behavioral Healthcare’s 2023 Clinical Outcomes Report Identifies Notable Symptom Improvement From Treatment

Odyssey Behavioral Healthcare’s 2023 Clinical Outcomes Report Identifies Notable Symptom Improvement From Treatment

BRENTWOOD, TN / ACCESSWIRE / July 16, 2024 / Odyssey Behavioral Healthcare ("Odyssey"), a leading provider of mental health, addiction,…

10 months ago
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 ConferenceClearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

10 months ago
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

10 months ago
Alleva Recognized in Software Advice FrontRunners for HIPAA Compliance Software Report 2024Alleva Recognized in Software Advice FrontRunners for HIPAA Compliance Software Report 2024

Alleva Recognized in Software Advice FrontRunners for HIPAA Compliance Software Report 2024

LAGUNA NIGUEL, Calif., July 2, 2024 /PRNewswire/ -- Alleva, a premier provider of electronic medical record (EMR) software solutions tailored…

11 months ago
Hazelden Betty Ford Foundation Announces Lineup for 75th Anniversary GalaHazelden Betty Ford Foundation Announces Lineup for 75th Anniversary Gala

Hazelden Betty Ford Foundation Announces Lineup for 75th Anniversary Gala

Rob Lowe to EmceeCenter City, Minnesota--(Newsfile Corp. - July 1, 2024) - On Friday, September 13, Hazelden Betty Ford Foundation,…

11 months ago
Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® IndexesAchieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes

SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

11 months ago